Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva® Advanced Cervical Scan, based on its patented biophotonic technology, announced today that it had received a new purchase order in the amount of $530,695 from its Chinese co-manufacturing partner and...
Established with Distribution Partner Newmars Technologies, Kft to Facilitate Sales and Marketing Starting in 2021 Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced the...
Guided Therapeutics, Inc. (OTCQB: GTHP) has developed a rapid and painless testing platform for the early detection of disease based on its patented biophotonic technology that utilizes light to detect disease at the cellular level. The company’s first product,...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless cervical cancer detection test based on its patented biophotonic technology, announced today the successful outcome of its October 14, 2020 meeting with FDA. The purpose of the meeting was to...
Books Nearly $77,000 in Revenue from Transaction Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced that it had shipped four LuViva Advanced Cervical Scan systems and...
